Columnist Jen Cueva has gotten more adept at listening to her body and making adjustments to manage her PH and leave room for joy.

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

Pulmonary hypertension (PH) risk grows over time for patients with narrowing of the aorta, the body's biggest blood vessel, ...

Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...

For columnist Anna Jeter, who's now post-transplant, protecting her health during the winter in Minnesota can be challenging ...

Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.

Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...

I’m the almost-pour-milk-onto-my-mom’s-plate-instead-of-in-her-cup kind of tired. The dump-potato-chips-instead-of-cat-food-into-my-cat’s-bowl kind of distracted. The ...

Recent news headlines have sparked significant concern among those of us in the pulmonary hypertension (PH) and other rare disease communities. The massive budget and staff cuts across multiple ...